Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.
about
Nonimmunologic targets of immunosuppressive agents in podocytesPodocyte pathology and nephropathy - sphingolipids in glomerular diseasesEffects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic NephropathyMonocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injuryElevated sphingosine-1-phosphate promotes sickling and sickle cell disease progressionTargeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.Plasma sphingosine-1-phosphate is elevated in obesityLipid biology of the podocyte--new perspectives offer new opportunities.Sphingosine-1-phosphate signaling and its role in disease.Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.Translational Aspects of Sphingolipid Metabolism in Renal Disorders.Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.Fructose downregulates miR-330 to induce renal inflammatory response and insulin signaling impairment: Attenuation by morin.
P2860
Q26781358-F218B948-0387-4314-9EBB-3BA562F83E56Q26852463-FAF3EF22-9D13-4182-B748-7653B006BF9BQ28080888-57577C6B-3B8D-4DFB-A5B4-7B32D9DF82C1Q30423561-0070B08A-C63C-4D04-84CC-6628DC8FA0BCQ33872564-3A4F8EEA-5F81-4BA6-BE30-439874F0C9A7Q34364844-35521815-6815-4E8B-B5CE-653A663BA35FQ34664459-6D2D47BC-930F-47F5-BC95-C46D94B16068Q34988407-C72B565A-6D66-4543-AB5A-04FD01F3BF5FQ35285568-960CB24A-0087-4BCD-9D7D-028C3B7346D5Q35661485-B4E95A45-DE6C-4FD3-9FEE-FED7FB3B1AC5Q38116071-FAC7E4DD-C6C8-4738-A3BF-9F2C91A4939CQ38831906-439588FD-B99A-43AB-B6E2-ABCAAC7E195BQ45072496-7F75DBE3-AE5D-4766-94E0-2E1BEB7A3D1DQ49399657-48C02917-C080-4317-BC73-33F9188327C2Q51287276-742B7E1F-E197-4364-B9A1-DD703F3CEFA8Q53633118-4B1A4B03-88EA-4437-B079-A2EFD196A7AAQ53750629-DDCED9C6-3979-4B41-B16C-00CDB7F174B4
P2860
Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chronic sphingosine 1-phosphat ...... hy independent of lymphocytes.
@ast
Chronic sphingosine 1-phosphat ...... hy independent of lymphocytes.
@en
type
label
Chronic sphingosine 1-phosphat ...... hy independent of lymphocytes.
@ast
Chronic sphingosine 1-phosphat ...... hy independent of lymphocytes.
@en
prefLabel
Chronic sphingosine 1-phosphat ...... hy independent of lymphocytes.
@ast
Chronic sphingosine 1-phosphat ...... hy independent of lymphocytes.
@en
P2093
P2860
P356
P1433
P1476
Chronic sphingosine 1-phosphat ...... hy independent of lymphocytes.
@en
P2093
Alaa S Awad
Kevin R Lynch
Konstantine Khutsishvili
Liping Huang
Michael D Rouse
W Kline Bolton
P2860
P2888
P304
P356
10.1038/KI.2010.544
P407
P577
2011-02-02T00:00:00Z
P5875
P6179
1000943916